Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of urological disorders
3.2.1.2 Growing preference for minimally invasive procedures
3.2.1.3 Technological advancements in catheters and stents
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risk of infection and discomfort due to stents and catheters
3.3 Regulatory landscape
3.4 Pipeline analysis
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Medication
5.2.1 Antibiotics
5.2.2 Alpha-blockers or alpha-reductase inhibitors
5.2.3 Other medication
5.3 Drainage devices
5.3.1 Catheters
5.3.1.1 Indwelling catheters
5.3.1.2 Intermittent catheter
5.3.1.3 Suprapubic catheter
5.3.2 Ureteral stents
5.4 Surgical procedure
5.5 Other treatment types
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Below 20
6.3 21 - 40
6.4 41 - 60
6.5 61 - 80
Chapter 7 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Specialty clinics
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 The Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Astellas Pharma Inc.
9.2 B. Braun Melsungen AG
9.3 Becton, Dickinson, and Company
9.4 Boston Scientific Corporation
9.5 Cook Medical
9.6 Glaxo SmithKline Pharmaceuticals Ltd.
9.7 Inceler Medikal Co. Ltd.
9.8 KARL STORZ
9.9 Purdue Pharma
9.10 Olympus America
9.11 Pfizer Inc.
9.12 Sun Pharmaceutical Industries Europe B.V.
9.13 Synthon BV
9.14 Teleflex Incorporated.
9.15 UROMED Kurt Drews KG
